Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	ZINC_FINGER_C2H2_1	ZNF438 ATF7 ZNF845 TUT4 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF804A ZNF518A ZFHX4 ZNF160	2.02e-05	777	102	15	PS00028
Domain	CCSER	CCSER2 CCSER1	2.95e-05	2	102	2	IPR029627
Domain	LAM_G_DOMAIN	LAMA1 EYS NRXN3 USH2A	5.37e-05	38	102	4	PS50025
Domain	Laminin_G_2	LAMA1 EYS NRXN3 USH2A	6.59e-05	40	102	4	PF02210
Domain	ZINC_FINGER_C2H2_2	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF804A ZNF518A ZFHX4 ZNF160	8.02e-05	775	102	14	PS50157
Domain	LamG	LAMA1 EYS NRXN3 USH2A	9.62e-05	44	102	4	SM00282
Domain	zf-C2H2	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF518A ZFHX4 ZNF160	1.01e-04	693	102	13	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF518A ZFHX4 ZNF160	1.03e-04	694	102	13	IPR013087
Domain	Znf_C2H2-like	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF804A ZNF518A ZFHX4 ZNF160	1.06e-04	796	102	14	IPR015880
Domain	Znf_C2H2	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF804A ZNF518A ZFHX4 ZNF160	1.20e-04	805	102	14	IPR007087
Domain	ZnF_C2H2	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF804A ZNF518A ZFHX4 ZNF160	1.25e-04	808	102	14	SM00355
Domain	Laminin_G	LAMA1 EYS NRXN3 USH2A	2.84e-04	58	102	4	IPR001791
Domain	ZnF_Rad18	FAN1 POLK	2.92e-04	5	102	2	SM00734
Domain	Znf_Rad18_put	FAN1 POLK	2.92e-04	5	102	2	IPR006642
Domain	-	ZNF438 ATF7 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZFHX4 ZNF160	3.28e-04	679	102	12	3.30.160.60
Domain	UCH	USP17L7 USP17L4 USP17L1 USP17L3	6.15e-04	71	102	4	PF00443
Domain	USP_2	USP17L7 USP17L4 USP17L1 USP17L3	6.15e-04	71	102	4	PS00973
Domain	USP_3	USP17L7 USP17L4 USP17L1 USP17L3	6.49e-04	72	102	4	PS50235
Domain	USP_dom	USP17L7 USP17L4 USP17L1 USP17L3	6.49e-04	72	102	4	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L4 USP17L1 USP17L3	6.49e-04	72	102	4	IPR001394
Domain	KRAB	ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 ZNF160	7.73e-04	358	102	8	PS50805
Domain	KRAB	ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 ZNF160	7.73e-04	358	102	8	PF01352
Domain	KRAB	ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 ZNF160	9.39e-04	369	102	8	SM00349
Domain	KRAB	ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 ZNF160	9.56e-04	370	102	8	IPR001909
Domain	Laminin_G_1	LAMA1 EYS	1.57e-03	11	102	2	PF00054
Domain	Ig-like_fold	SEMA4B FLT3 ROR1 PTGFRN IGSF10 CD3G ZPBP2 IL1RL1 MDGA1 USH2A CXADR	1.63e-03	706	102	11	IPR013783
Domain	Ig-like_dom	FLT3 ROR1 PTGFRN IGSF10 CD3G ZPBP2 IL1RL1 MDGA1 CXADR	1.73e-03	503	102	9	IPR007110
Domain	-	LAMA1 EYS NRXN3 USH2A	1.82e-03	95	102	4	2.60.120.200
Domain	IGc2	ROR1 IGSF10 CD3G IL1RL1 MDGA1 CXADR	1.83e-03	235	102	6	SM00408
Domain	Ig_sub2	ROR1 IGSF10 CD3G IL1RL1 MDGA1 CXADR	1.83e-03	235	102	6	IPR003598
Domain	-	FLT3 ROR1 PTGFRN IGSF10 CD3G ZPBP2 IL1RL1 MDGA1 USH2A CXADR	3.36e-03	663	102	10	2.60.40.10
Domain	Laminin_N	LAMA1 USH2A	3.37e-03	16	102	2	IPR008211
Domain	HABP4_PAI-RBP1	USP17L7 USP17L3	3.37e-03	16	102	2	PF04774
Domain	LamNT	LAMA1 USH2A	3.37e-03	16	102	2	SM00136
Domain	LAMININ_NTER	LAMA1 USH2A	3.37e-03	16	102	2	PS51117
Domain	Laminin_N	LAMA1 USH2A	3.37e-03	16	102	2	PF00055
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L3	3.37e-03	16	102	2	IPR006861
Domain	Ig_I-set	ROR1 IGSF10 IL1RL1 MDGA1 CXADR	3.88e-03	190	102	5	IPR013098
Domain	I-set	ROR1 IGSF10 IL1RL1 MDGA1 CXADR	3.88e-03	190	102	5	PF07679
Domain	-	SMCHD1 SACS	5.26e-03	20	102	2	3.30.565.10
Domain	IG_LIKE	FLT3 ROR1 PTGFRN IGSF10 CD3G IL1RL1 MDGA1 CXADR	5.47e-03	491	102	8	PS50835
Domain	USP_CS	USP17L7 USP17L1 USP17L3	5.64e-03	66	102	3	IPR018200
Domain	C2	PLA2G4E FER1L6 PRKCH MCTP2	5.78e-03	131	102	4	PF00168
Domain	HATPase_C	SMCHD1 SACS	5.80e-03	21	102	2	IPR003594
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	3.85e-06	45	75	5	MM15671
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.67e-11	10	105	5	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	1.77e-10	12	105	5	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-10	14	105	5	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	2.56e-09	19	105	5	28067227
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.46e-09	21	105	5	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.76e-09	22	105	5	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	9.25e-09	24	105	5	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	1.15e-08	25	105	5	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	1.42e-08	26	105	5	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	2.55e-08	29	105	5	32527007
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.06e-08	33	105	5	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	20403174
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	20388806
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	14699124
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	20368735
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	11941478
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.91e-08	34	105	5	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	6.88e-08	35	105	5	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	6.88e-08	35	105	5	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	7.97e-08	36	105	5	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	9.20e-08	37	105	5	20228808
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15 TMPRSS11A	1.77e-07	81	105	6	12838346
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF13B SEMA4B RNF213 ZFC3H1 PTGFRN FAN1 NEK1 SACS PRORP ZNF160 CCSER1	3.12e-07	493	105	11	15368895
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 KCNU1 USP17L3	3.52e-07	48	105	5	16421571
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.33e-07	50	105	5	31806660
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	SEMA4B FLT3 ROR1 PTGFRN IGSF10 MDGA1 CXADR	6.48e-07	162	105	7	25826454
Pubmed	Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.	FLT3 ENPP2	9.03e-06	2	105	2	23377000
Pubmed	Interaction of Human OATP1B1 with PDZK1 Is Required for Its Trafficking to the Hepatocyte Plasma Membrane.	PDZK1 SLCO1B1	9.03e-06	2	105	2	37442606
Pubmed	The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline.	MEIOC DDX4 MYBL1	1.18e-05	15	105	3	29087293
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	USP17L7 ROR1 LAMA1 RNF213 HUWE1 IGSF10 USP17L3 UTP20 ANKRD18A TNFAIP1 C6	1.45e-05	736	105	11	29676528
Pubmed	The transcription factor Rreb1 regulates epithelial architecture, invasiveness, and vasculogenesis in early mouse embryos.	LAMA1 RREB1 CDH2	1.46e-05	16	105	3	33929320
Pubmed	Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery.	CCR6 IL1RL1	5.40e-05	4	105	2	30602786
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	RNF213 HUWE1 SACS ENAH	8.51e-05	76	105	4	27542412
Pubmed	Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum.	GRID2 NRXN3	8.97e-05	5	105	2	20537373
Pubmed	Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.	CD3G CCR6	8.97e-05	5	105	2	21984702
Pubmed	mGluR5 regulates REST/NRSF signaling through N-cadherin/β-catenin complex in Huntington's disease.	GRM5 CDH2	8.97e-05	5	105	2	32859226
Pubmed	Shroom3 and a Pitx2-N-cadherin pathway function cooperatively to generate asymmetric cell shape changes during gut morphogenesis.	SHROOM3 CDH2	8.97e-05	5	105	2	21726547
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	ZNF211 ZNF230 DNAJC7 CCSER2 CCSER1	9.83e-05	151	105	5	17043677
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DENND4A SMCHD1 ZFC3H1 RBM39 ZFHX4 NUP153 TMPRSS11A	1.17e-04	361	105	7	26167880
Pubmed	Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.	FLT3 CCR6	1.34e-04	6	105	2	23395676
Pubmed	Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease.	NRXN3 UTP20	1.34e-04	6	105	2	20197096
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATF7 SHROOM3 TUT4 MAEA RNF213 HUWE1 RBM39 HPN ENAH SMARCA2 UBA6 PRORP POLK MCTP2	1.57e-04	1489	105	14	28611215
Pubmed	Neurexophilin binding to alpha-neurexins. A single LNS domain functions as an independently folding ligand-binding unit.	NXPH1 NRXN3	1.88e-04	7	105	2	9856994
Pubmed	Glycosylation of Cblns attenuates their receptor binding.	GRID2 NRXN3	1.88e-04	7	105	2	29782851
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	RNF213 HUWE1 HACE1 UBA6	2.02e-04	95	105	4	29643511
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF845 ZNF211 MAEA ZNF195 ZNF160	2.29e-04	181	105	5	37372979
Pubmed	GluD1 is a signal transduction device disguised as an ionotropic receptor.	GRID2 NRXN3	2.50e-04	8	105	2	34135511
Pubmed	Essential role of citron kinase in cytokinesis of spermatogenic precursors.	DDX4 MYBL1	2.50e-04	8	105	2	12432070
Pubmed	p120-catenin-dependent junctional recruitment of Shroom3 is required for apical constriction during lens pit morphogenesis.	SHROOM3 CDH2	2.50e-04	8	105	2	25038041
Pubmed	RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis.	MEIOC DDX4	3.21e-04	9	105	2	36001654
Pubmed	A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage.	BMP5 CHRDL1	3.21e-04	9	105	2	14660436
Pubmed	The changing landscape of immune cells in the fetal mouse testis.	CD3G DDX4	3.21e-04	9	105	2	35829816
Pubmed	Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors.	PDZK1 RREB1	3.21e-04	9	105	2	20884846
Pubmed	DNA cross-link repair safeguards genomic stability during premeiotic germ cell development.	FAN1 DDX4	3.21e-04	9	105	2	31367016
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	SEMA4B TUT4 PLA2G4E ITK NEK1 SMARCA2 UBA6 PRKCH TNFAIP1	3.77e-04	730	105	9	34857952
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TUT4 SMCHD1 LAMA1 SMARCA2 DDX4	3.88e-04	203	105	5	22083510
Pubmed	Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves.	CDH2 CXADR	4.00e-04	10	105	2	16543498
Pubmed	Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.	CD3G PRKCH	4.00e-04	10	105	2	2139676
Pubmed	SOX17 links gut endoderm morphogenesis and germ layer segregation.	LAMA1 CDH2	4.00e-04	10	105	2	25419850
Pubmed	Werner helicase-interacting protein 1 binds polyubiquitin via its zinc finger domain.	FOXN2 HUWE1 UBA6	4.73e-04	50	105	3	17550899
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	ZFC3H1 DNAJC7 CCSER2 CCSER1	4.92e-04	120	105	4	31413325
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	KLHL6 HUWE1 EYS PTPN14 SACS WDR1	5.27e-04	332	105	6	37433992
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	KLHL6 ATF7 ZNF559 SPAG7 RREB1 DNAJC7 FAN1 CHRDL1 PRKCH PRORP MCTP2 PRIMPOL	5.36e-04	1293	105	12	15342556
Pubmed	Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.	FLT3 CCR6	5.84e-04	12	105	2	21029863
Pubmed	Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy.	ROR1 PTGFRN CDH2	6.26e-04	55	105	3	38945485
Pubmed	Overview of inactivating mutations in the protein-coding genome of the mouse reference strain C57BL/6J.	PDZK1 LAMA1 ZNF195	6.26e-04	55	105	3	29997285
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	SMCHD1 RBM39 SMARCA2 WDR1	6.85e-04	131	105	4	34551306
Pubmed	UHRF1 establishes crosstalk between somatic and germ cells in male reproduction.	CDH2 DDX4	6.89e-04	13	105	2	35440090
Pubmed	Trim33 Binds and Silences a Class of Young Endogenous Retroviruses in the Mouse Testis; a Novel Component of the Arms Race between Retrotransposons and the Host Genome.	CHRDL1 MYBL1	6.89e-04	13	105	2	26624618
Pubmed	Regulation of error-prone translesion synthesis by Spartan/C1orf124.	HUWE1 DNAJC7 RBM39	7.69e-04	59	105	3	23254330
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	SMARCA2 DDX4	8.02e-04	14	105	2	36289231
Pubmed	The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.	LAMA1 CDH2	8.02e-04	14	105	2	9151674
Pubmed	Trophectoderm mechanics direct epiblast shape upon embryo implantation.	LAMA1 CDH2	8.02e-04	14	105	2	33472064
Pubmed	Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects.	SMCHD1 HUWE1	9.24e-04	15	105	2	30970248
Pubmed	Neural defects caused by total and Wnt1-Cre mediated ablation of p120ctn in mice.	SHROOM3 CDH2	9.24e-04	15	105	2	32741376
Pubmed	The non-canonical Wnt-PCP pathway shapes the mouse caudal neural plate.	SHROOM3 CDH2	9.24e-04	15	105	2	29636380
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	LAMA1 NUP153	9.24e-04	15	105	2	14697343
Pubmed	Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.	KIF13B SRR CCSER1	1.02e-03	65	105	3	23319000
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	TUT4 PDZK1 VPS50 HUWE1 RREB1 DNAJC7 F11 EYS PRKCH WDR1	1.02e-03	1016	105	10	19056867
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L4 USP17L1 PLA2G4E BCLAF3 USP17L3 MDGA1 USP17L15	1.02e-03	674	105	8	37196079
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF845 FAM76B ZFC3H1 PTGFRN ZNF518A CCSER2 WDR1 ZNF160 CDH2 CXADR RNF111	1.04e-03	1203	105	11	29180619
Pubmed	Gtsf1/Cue110, a gene encoding a protein with two copies of a CHHC Zn-finger motif, is involved in spermatogenesis and retrotransposon suppression in murine testes.	DDX4 MYBL1	1.05e-03	16	105	2	19735653
Pubmed	Genome-wide association of body fat distribution in African ancestry populations suggests new loci.	RREB1 IL1RL1	1.05e-03	16	105	2	23966867
Pubmed	A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.	CD3G PRKCH	1.05e-03	16	105	2	1832084
Pubmed	Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.	FLT3 ITK	1.05e-03	16	105	2	10022833
Pubmed	Neural plate morphogenesis during mouse neurulation is regulated by antagonism of Bmp signalling.	BMP5 CHRDL1	1.19e-03	17	105	2	17693602
Pubmed	Mili, a mammalian member of piwi family gene, is essential for spermatogenesis.	DDX4 MYBL1	1.19e-03	17	105	2	14736746
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	SMCHD1 HUWE1 DNAJC7 RBM39 WDR1 ALDH5A1 NUP153	1.21e-03	534	105	7	35032548
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ROR1 PTPN14 MEIOC CCSER2 NUP153	1.24e-03	263	105	5	34702444
Cytoband	8q24.1	ENPP2 FER1L6	1.08e-04	7	105	2	8q24.1
Cytoband	8p23.1	USP17L7 USP17L4 USP17L1 USP17L3	4.47e-04	154	105	4	8p23.1
Cytoband	5q13	HEXB POLK	1.16e-03	22	105	2	5q13
Cytoband	13q12	FLT3 SACS	1.38e-03	24	105	2	13q12
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L1 USP17L3	2.10e-03	234	105	4	chr8p23
Cytoband	4q13.2	UBA6 TMPRSS11A	2.31e-03	31	105	2	4q13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr4q35	CCDC110 F11 PRIMPOL	2.50e-03	117	105	3	chr4q35
Cytoband	4q35.1	CCDC110 PRIMPOL	3.10e-03	36	105	2	4q35.1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF438 ZNF845 ZNF211 ZNF559 ZNF195 ZNF510 ZNF230 ZNF285 RREB1 ZNF518A ZNF160	9.16e-05	718	70	11	28
GeneFamily	Immunoglobulin like domain containing	FLT3 PTGFRN ZPBP2 IL1RL1 MDGA1 CXADR	1.02e-04	193	70	6	594
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L4 USP17L1 USP17L3 DDX4 USP17L15	1.30e-06	86	105	6	MM1312
Coexpression	GSE10325_CD4_TCELL_VS_BCELL_UP	ITK CD3G CCSER2 PRKCH WDR1 PRORP ZMYM6 MYBL1	1.42e-06	199	105	8	M3076
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	FOXN2 DENND4A TUT4 SMCHD1 RNF213 ZFC3H1 HUWE1 RBM39 ITK CD3G SACS CCSER2 SMARCA2 PRKCH CCR6 WDR1 NUP153 MYBL1	2.51e-05	1492	105	18	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TUT4 SMCHD1 ROR1 ZNF804A RBM39 NEK1 SACS CCSER2 SMARCA2 UTP20 CDH2 NUP153 MYBL1	3.84e-05	856	105	13	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	TUT4 ENPP2 SMCHD1 ZNF195 DNAJC7 NEK1 SACS ENAH SMARCA2 POLK MYBL1	6.57e-05	656	105	11	M18979
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	8.95e-05	112	105	5	MM1095
Coexpression	GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP	ATF7 ROR1 SLCO1B1 ZNF804A BCLAF3 SMARCA2	1.19e-04	190	105	6	M8190
Coexpression	PGF_UP.V1_UP	ROR1 F11 NEK1 SACS IL1RL1 LRRC17	1.19e-04	190	105	6	M2674
Coexpression	GSE369_IFNG_KO_VS_WT_LIVER_UP	TUT4 FAM76B SRR ZFC3H1 ZNF518A RNF111	1.53e-04	199	105	6	M5970
Coexpression	GSE3982_BCELL_VS_TH1_UP	ZNF211 TRHR ZNF510 ZNF804A DACT1 ALDH5A1	1.53e-04	199	105	6	M5551
Coexpression	GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	CD3G SACS SMARCA2 PRORP ZMYM6 MYBL1	1.53e-04	199	105	6	M4427
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP	TUT4 ITK CD3G PRKCH PRORP MYBL1	1.53e-04	199	105	6	M3087
Coexpression	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP	HEXB PDZK1 ITK MDGA1 MCTP2 CCSER1	1.57e-04	200	105	6	M8098
Coexpression	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	KLHL6 SEMA4B SMCHD1 FAM76B ZFC3H1 RBM39	1.57e-04	200	105	6	M8088
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	HEXB TUT4 SMCHD1 ZFC3H1 RREB1 ZPBP2	1.57e-04	200	105	6	M8090
Coexpression	GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN	BCLAF3 NEK1 CCSER2 UTP20 POLK DDX4	1.57e-04	200	105	6	M7418
Coexpression	LEE_DIFFERENTIATING_T_LYMPHOCYTE	KLHL6 ITK CD3G PRKCH ZNF160 ALDH5A1	1.62e-04	201	105	6	M2200
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMCHD1 RNF213 RBM39 ITK CD3G PRKCH MCTP2 MYBL1	1.59e-08	190	104	8	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	Control-Lymphoid-T\|World / Disease state, Lineage and Cell class	DENND4A SMCHD1 ITK CD3G CCSER2 SMARCA2 PRKCH CCR6	1.72e-08	192	104	8	253cf4d2cf88ad8c45b73779336180840bef054b
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMCHD1 RNF213 ZFC3H1 RBM39 ITK SMARCA2 IL1RL1 MYBL1	2.11e-08	197	104	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMCHD1 RNF213 ZFC3H1 RBM39 ITK PRKCH MCTP2 MYBL1	2.28e-08	199	104	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF213 ITK DNAI1 CD3G PRKCH PRORP MYBL1	1.19e-07	164	104	7	24fdea5113d92b96f56b06dd2449910a3c785e69
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 CCDC110 ROR1 NRXN3 HPN SEC14L2 CXADR	2.69e-07	185	104	7	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 ITK EYS CD3G HPN PRKCH CCR6	3.11e-07	189	104	7	723c57f278919e8251d56b3d19411f9088319450
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 ITK EYS CD3G HPN PRKCH CCR6	3.11e-07	189	104	7	960374f5fb278659500a7c948c3068a95dd62eb0
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS ANKRD18A	3.22e-07	190	104	7	3f22c118d552345f731d4d49f0bcb5765d93de3b
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	KIF13B SMCHD1 RNF213 HUWE1 ITK MCTP2 RNF111	3.34e-07	191	104	7	9454f642c3621370fa23640b631301346b300950
ToppCell	COPD-Lymphoid-T\|World / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 SMARCA2 PRKCH CCR6	3.46e-07	192	104	7	eb4909574fb5fc91399463523e2737095773200a
ToppCell	COPD-Lymphoid\|COPD / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH MCTP2 MYBL1	3.46e-07	192	104	7	064fefb8212fadab0ff441f4bf643559b7fdb25d
ToppCell	IPF-Lymphoid-T\|World / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 SMARCA2 PRKCH CCR6	3.46e-07	192	104	7	b25ba1f3bc842c22602b2aeed3b1b5082863e4fa
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SMCHD1 RNF213 ITK CD3G CCSER2 PRKCH MYBL1	3.46e-07	192	104	7	ed1fb700d3e8f00495727d61e164fc0b70274fd0
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SMCHD1 RNF213 ITK CD3G CCSER2 PRKCH MYBL1	3.46e-07	192	104	7	6779b0294bb058e748e22b795b6a381c4add37e9
ToppCell	Control-Lymphoid-T\|Control / Disease state, Lineage and Cell class	DENND4A SMCHD1 ITK CD3G CCSER2 SMARCA2 CCR6	3.58e-07	193	104	7	af928046ccd1ca874be1534aef6ca7f27d90bc46
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A SMCHD1 ITK CD3G CCSER2 SMARCA2 PRKCH	3.58e-07	193	104	7	9c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 RNF213 ITK CD3G HPN PRKCH MYBL1	3.71e-07	194	104	7	5afe7f48d3383f3dac18765f97999c8b6936dc1b
ToppCell	10x5'v1-week_12-13-Lymphocytic_NK-T_NK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 RNF213 ITK CD3G HPN PRKCH MYBL1	3.71e-07	194	104	7	ec7e0ca6c9a2f63938e06ee771da09eff14fc3b5
ToppCell	Control-Lymphoid\|Control / Disease state, Lineage and Cell class	ITK CD3G CCSER2 PRKCH CCR6 MCTP2 MYBL1	3.71e-07	194	104	7	d5b124f15c953eeb7e8e990df44d7fa466f2b31f
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	3.84e-07	195	104	7	ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66
ToppCell	nucseq-Immune-Lymphocytic_T/NK\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND4A SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	3.84e-07	195	104	7	b8124e8a23e6d37b40023608674e67285c6ffe84
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DENND4A TUT4 SMCHD1 ITK CD3G CCSER2 PRKCH	3.84e-07	195	104	7	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 SMARCA2 PRKCH CCR6	3.98e-07	196	104	7	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ITK CD3G CCSER2 SMARCA2 PRKCH CCR6 MYBL1	4.11e-07	197	104	7	51340570667914bffec741c72a8d09cc46abb8e8
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMCHD1 RNF213 RBM39 CD3G CCSER2 PRKCH MYBL1	4.56e-07	200	104	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NXPH1 GRID2 GRM5 EYS KCNU1 USH2A	1.33e-06	148	104	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	DENND4A SMCHD1 RNF213 RBM39 ITK PRKCH	1.81e-06	156	104	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TDRD15 ITK CD3G PRKCH MDGA1	2.50e-06	165	104	6	8dbd03795fff060cd2e4d5d97348f5b63515e030
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TDRD15 ITK CD3G PRKCH MDGA1	2.50e-06	165	104	6	5fc5e34cc805df44c020256729256ef761790152
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL6 TDRD15 ITK CD3G PRKCH MDGA1	2.50e-06	165	104	6	64c7c45383afde1d050934938705e47aa615755f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITK SACS CCSER2 PRKCH CCR6 MYBL1	2.68e-06	167	104	6	83969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITK FAN1 CD3G CCSER2 CCR6 NUP153	2.98e-06	170	104	6	adb625124832b0786a590e8f75b61e7263a1e0d4
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DENND4A TUT4 SMCHD1 RNF213 RBM39 ITK	3.08e-06	171	104	6	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Healthy_donor-MAIT\|World / disease group, cell group and cell class (v2)	CCDC110 CD3G PRKCH CCR6 CDH2 MYBL1	3.18e-06	172	104	6	6524eb2be1c78700ad367e62624a4d7eb48b54f0
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TUT4 ZNF195 ITK CD3G ZNF160 MYBL1	4.01e-06	179	104	6	6bbb32d7e582a96cb3cfc3eb911b05d518e7d5e9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITK CD3G CCSER2 PRKCH CCR6 MYBL1	4.14e-06	180	104	6	d9dae9db8e17f6990032ee6cfa8393fae4768ca5
ToppCell	normal-na-Lymphocytic_T-CytoT_GZMK+-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	SMCHD1 RNF213 CD3G CCSER2 PRKCH MYBL1	4.55e-06	183	104	6	79defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	4.55e-06	183	104	6	04d3cc76038b8192c915f1c08c3e26f2ad3b3779
ToppCell	IPF-Lymphoid-ILC_A\|IPF / Disease state, Lineage and Cell class	DENND4A ITK CCSER2 PRKCH MCTP2 MYBL1	4.55e-06	183	104	6	49bfeaae13eb236f61a5486ee75c39789936bb8a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA4B DENND4A LAMA1 PTPN14 HPN MCTP2	5.15e-06	187	104	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	5.31e-06	188	104	6	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ITK CCSER2 PRKCH IL1RL1 MCTP2 MYBL1	5.31e-06	188	104	6	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	Control-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	ITK CD3G CCSER2 PRKCH MCTP2 MYBL1	5.47e-06	189	104	6	ee4c1d930534788a7759d92dc8ff9c62e6ee2301
ToppCell	COPD\|World / Disease state, Lineage and Cell class	DENND4A SMCHD1 ITK CD3G PRKCH MCTP2	5.47e-06	189	104	6	53577632683686dc493a5a3fdc01887ec5c320f2
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 ITK CD3G HPN PRKCH CCR6	5.64e-06	190	104	6	67fa7472ec534179087963177351552cc3c335eb
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDZK1 ITK CD3G HPN PRKCH CCR6	5.64e-06	190	104	6	094efcde2b037ae509298abb8b2b1d52f9c86a45
ToppCell	IPF-Lymphoid-T_Cytotoxic\|IPF / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	5.64e-06	190	104	6	e5d0186bfb416a3eda76ac12b9379650afb6f409
ToppCell	IPF-Lymphoid-T\|IPF / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH CCR6	5.64e-06	190	104	6	d57df208aaf7a5554899bb9107c80b443fd0cf93
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	5.64e-06	190	104	6	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	5.64e-06	190	104	6	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	COVID-19-T_cells-CD4+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	5.81e-06	191	104	6	0646cca78e24aeb6baa9934d3c439b797c567997
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	5.81e-06	191	104	6	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	COPD-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	5.99e-06	192	104	6	5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	DENND4A SMCHD1 RNF213 RBM39 ITK PRKCH	5.99e-06	192	104	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A EYS ANKRD18A	5.99e-06	192	104	6	0003d7ef9a8e521e70ac33c63aad843d9b6215c2
ToppCell	COPD-Lymphoid-T_Cytotoxic\|COPD / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	6.17e-06	193	104	6	58e94fe2e89cdafc6974938f97a4c162061a437d
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 PTGFRN IGSF10 ZFHX4 CHRDL1 LRRC17	6.17e-06	193	104	6	316ebdf15f75d88c348f909b643fcd315364ca84
ToppCell	droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 PTGFRN IGSF10 ZFHX4 CHRDL1 LRRC17	6.17e-06	193	104	6	1afdd3f7d703f4204a2cbfe40e135ac7b09213f7
ToppCell	IPF-Lymphoid\|IPF / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G PRKCH MCTP2 MYBL1	6.17e-06	193	104	6	bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCell	IPF-Lymphoid-T_Cytotoxic\|World / Disease state, Lineage and Cell class	SMCHD1 ITK CD3G CCSER2 PRKCH MYBL1	6.17e-06	193	104	6	35c902a983d7f1156a74fe68ee366609029833b3
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	6.17e-06	193	104	6	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	droplet-Fat-Scat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENPP2 PTGFRN IGSF10 ZFHX4 CHRDL1 LRRC17	6.17e-06	193	104	6	8dc6db335678f3a5cfd36026ad811fed8d9cb4bc
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ITK CD3G HPN CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	5a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	e72be6dc2711c1d4f16943c8615cf9dc2e961ff3
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TUT4 SMCHD1 ITK CD3G CCSER2 CCR6	6.35e-06	194	104	6	0b0042b6a356a49a059fb64a1e1abb25c82d48cf
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	ac03be73fdc32dacd4a450c0fb28617e043b8444
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ITK CD3G HPN CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	7d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	68e9ad254fe94e2f59cf5c2b2ea3e1245cb85104
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	7ab4418a8a12c488d74af3676bdac672628da80c
ToppCell	severe_COVID-19-CD4+_CTL\|World / disease group, cell group and cell class (v2)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	bdafc1173b7b8cde8714573fbeee5394a2484a5f
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.35e-06	194	104	6	760761ce7d22edf9a8cec71e8ab0caa273fce3f7
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.74e-06	196	104	6	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.74e-06	196	104	6	093fb240e72911dfd360aa6edf8ed2d611c78a1e
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD8+_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.74e-06	196	104	6	c06caba0c91b8ee66f42bc43ec75eb2475f07056
ToppCell	IPF-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	KIF13B FOXN2 ITK SMARCA2 CCR6 PRORP	6.74e-06	196	104	6	6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUT4 SMCHD1 RBM39 ITK CD3G PRKCH	6.94e-06	197	104	6	ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ENPP2 ROR1 IGSF10 BMP5 ENAH LRRC17	6.94e-06	197	104	6	31a1852911bda38543916585fda34255fd62a134
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LRRC66 RNF213 ITK PRKCH MCTP2 MYBL1	6.94e-06	197	104	6	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	severe_COVID-19-CD4+_CTL\|severe_COVID-19 / disease group, cell group and cell class (v2)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	6.94e-06	197	104	6	e51b7cd03b1450dc8601b4be0453b104d6a5f955
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	KIF13B ENPP2 ROR1 BMP5 ENAH MCTP2	6.94e-06	197	104	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TUT4 SMCHD1 RNF213 ITK CD3G PRKCH	7.14e-06	198	104	6	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	COVID-19_Moderate-CD8+_Tem\|World / disease group, cell group and cell class	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	7.14e-06	198	104	6	1d12be256af028c88e31fb535068bae16b7bd48e
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_CTL\|World / disease group, cell group and cell class (v2)	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	7.14e-06	198	104	6	03c01fc384d46eec55ff730edbab8a3fde618ed8
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TUT4 RNF213 ITK CD3G PRKCH MYBL1	7.35e-06	199	104	6	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	Bronchus_Control_(B.)-Immune-TX-T_cells\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	RNF213 ITK CD3G PRKCH CCR6 MYBL1	7.35e-06	199	104	6	cb4cd42e608126227cbbf2342486550bcd4d0fc9
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 GRID2 EYS NRXN3	7.56e-06	200	104	6	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 GRID2 EYS NRXN3	7.56e-06	200	104	6	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Control-Control-Lymphocyte-T/NK-CD8+_Tem\|Control / Disease, condition lineage and cell class	RNF213 ITK CD3G CCSER2 PRKCH MYBL1	7.56e-06	200	104	6	fddb3df5b90eb97ef8ed80fac320c1a90903f012
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	7.56e-06	200	104	6	c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 RBM39 CD3G CCSER2 PRKCH MYBL1	7.56e-06	200	104	6	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 GRID2 EYS NRXN3	7.56e-06	200	104	6	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	7.56e-06	200	104	6	117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FLT3 ROR1 NXPH1 ZNF804A DNAI1 EYS	7.56e-06	200	104	6	d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCell	COVID-19-kidney-Mito-rich_Int\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NXPH1 GRID2 PLA2G4E EYS KCNU1	1.00e-05	122	104	5	a4220adb4e6055a599bd9bbf65d460fc4e68b543
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FLT3 CCR6 LRRC17 MYBL1 CCSER1	2.16e-05	143	104	5	5a279da1cd8e63db32f7c85a73b493c2121d0a96
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FLT3 CCR6 LRRC17 MYBL1 CCSER1	2.31e-05	145	104	5	997bd540c43725a85ca97e4b79ebe0d336860287
ToppCell	Children_(3_yrs)-Immune-dendritic_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FOXN2 FLT3 CCR6 MYBL1 CCSER1	2.89e-05	152	104	5	0769857f25da2e6169420818e61d65e33b7277b1
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	RNF213 ITK PRKCH ANKRD18A MYBL1	3.28e-05	156	104	5	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZFC3H1 ZNF230 ENAH IL1RL1 CXADR	3.48e-05	158	104	5	74aa4f75307575ac3b2b1aa9f727753692f88742
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	5.75e-07	46	103	5	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L4 USP17L1 USP17L3 USP17L15	4.42e-06	69	103	5	DOID:1682 (implicated_via_orthology)
Disease	level of coagulation factor XI in blood serum	F11 ZNF160	1.21e-05	2	103	2	OBA_2041532
Disease	intracranial thrombosis	F11 ZNF160	3.61e-05	3	103	2	MONDO_0002907
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	ZNF438 FLT3 FAM76B CCR6	7.12e-05	63	103	4	EFO_0000685, EFO_0007791, EFO_0009459
Disease	T-cell immunoglobulin and mucin domain 1 measurement	PTGFRN ITK	2.51e-04	7	103	2	EFO_0010812
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	ZNF438 FLT3 FAM76B PRKCH CCR6	3.32e-04	170	103	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	factor XI measurement	F11 ZNF160	3.33e-04	8	103	2	EFO_0004694
Disease	tetradecanedioate measurement	SLCO1B1 MDGA1	4.28e-04	9	103	2	EFO_0021057
Disease	neurotic disorder	NXPH1 GRM5 ZNF804A CCSER1	4.41e-04	101	103	4	EFO_0004257
Disease	cleft lip	TRHR NXPH1 GRM5 PTGFRN CCR6 MDGA1	4.94e-04	284	103	6	EFO_0003959
Disease	daytime rest measurement	TRHR ITK NEK1 NRXN3 MDGA1 CDH2	6.03e-04	295	103	6	EFO_0007828
Disease	Drug habituation	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0013170
Disease	Drug abuse	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0013146
Disease	Prescription Drug Abuse	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C4316881
Disease	Substance-Related Disorders	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0236969
Disease	Drug Use Disorders	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0013222
Disease	Drug Dependence	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C1510472
Disease	Substance Dependence	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0038580
Disease	Substance Use Disorders	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	GRM5 ZNF804A NRXN3 PRKCH	7.19e-04	115	103	4	C0029231
Disease	smoking status measurement	ZNF438 GRID2 SRR GRM5 ZNF518A NRXN3 HACE1 WDR1 MDGA1 USH2A CDH2 CCSER1	7.31e-04	1160	103	12	EFO_0006527
Disease	Substance abuse problem	GRM5 ZNF804A NRXN3 PRKCH	7.43e-04	116	103	4	C0740858
Disease	rheumatoid arthritis	ZNF438 FLT3 FAM76B GRM5 PRKCH CCR6 ZPBP2	1.20e-03	462	103	7	EFO_0000685
Disease	Hallux valgus	NXPH1 EYS HACE1	1.22e-03	60	103	3	HP_0001822
Disease	response to statin, LDL cholesterol change measurement	TDRD15 SLCO1B1	1.23e-03	15	103	2	EFO_0007804, GO_0036273
Disease	Schizoaffective disorder-bipolar type	ZNF804A NRXN3	1.40e-03	16	103	2	EFO_0009965
Disease	susceptibility to cold sores measurement	GRID2 SLCO1B1 BMP5	1.54e-03	65	103	3	EFO_0008402
Disease	factor XI measurement, Ischemic stroke	F11 ZNF160	1.59e-03	17	103	2	EFO_0004694, HP_0002140
Disease	testosterone measurement	ZNF438 SHROOM3 DENND4A RREB1 SLCO1B1 DACT1 BMP5 ZFHX4 HPN SMARCA2 CHRDL1 USH2A	1.64e-03	1275	103	12	EFO_0004908
Disease	schizophrenia (implicated_via_orthology)	SRR GRM5 ZNF804A	1.76e-03	68	103	3	DOID:5419 (implicated_via_orthology)
Disease	facial asymmetry measurement	ROR1 NRXN3	1.99e-03	19	103	2	EFO_0009751
Disease	free androgen index	SMCHD1 RREB1 SLCO1B1 ZFHX4 HPN SMARCA2	2.03e-03	374	103	6	EFO_0007005
Disease	alpha-tocopherol measurement	USH2A SEC14L2	2.20e-03	20	103	2	EFO_0007898
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	F11 ZNF160	2.43e-03	21	103	2	EFO_0004286, EFO_0004792
Disease	citrate measurement	SHROOM3 SLCO1B1 CDH2	2.69e-03	79	103	3	EFO_0010114
Disease	venous thromboembolism, tissue plasminogen activator measurement	F11 ZNF160	2.91e-03	23	103	2	EFO_0004286, EFO_0004791
Disease	partial thromboplastin time	F11 ZNF160	3.17e-03	24	103	2	EFO_0004310
Disease	supramarginal gyrus volume measurement	NEK1 PRORP	3.17e-03	24	103	2	EFO_0010332
Disease	autoimmune disease	FLT3 FAM76B ZPBP2 SEC14L2	3.21e-03	173	103	4	EFO_0005140
Disease	aggressive behavior	F11 ZNF160	3.44e-03	25	103	2	EFO_0003015
Disease	FEV change measurement, response to zileuton	CCR6 PRORP	3.44e-03	25	103	2	EFO_0005921, EFO_0007676

Protein segments in the cluster

Peptide	Gene	Start	Entry
QCKGSQNKSKPLQVY	CD3G	86	P09693
NTDKLKNVSSNYCLG	nan	216	Q9N2J8
SENKQPQDSQSYGKK	ANKRD18A	306	Q8IVF6
CQTLNNNIAKAGYTK	DDX4	296	Q9NQI0
QSALQDKKDSYQPVC	TNFAIP1	121	Q13829
NQKYNTQGSDVCEPK	CCR6	186	P51684
KDCPVTALQKKTQGY	ATF7	396	P17544
AADQTSPYKNKTCQL	CCSER1	771	Q9C0I3
KYEAICNQPVAAKKN	DNAI1	616	Q9UI46
TKGSADCLPKLSYQN	DENND4A	946	Q7Z401
DKNSAQGNVYVKCPS	RBM39	466	Q14498
NPRECKLSKQEGQNY	PDZK1	6	Q5T2W1
YNCTATNNVGNPAKK	MDGA1	306	Q8NFP4
PQENSKYNKTCNSSL	GRM5	371	P41594
GPNGKLATDKTQCYD	KLHL6	476	Q8WZ60
SIRDGQPNCYVLKNK	MCTP2	596	Q6DN12
QAGLSAIKTPQCYKE	MAEA	291	Q7L5Y9
PSKAVKNYHINNCRS	EYS	2051	Q5T1H1
SPEICENKPYNNKSD	NEK1	171	Q96PY6
LGNYAKCESPQEQKN	LRRC17	186	Q8N6Y2
PKNGQCDLYSSVDTK	GRID2	806	O43424
KKGANPNYQDISGCT	HACE1	86	Q8IYU2
CNSSKGPETLYAGQK	NRXN3	756	Q9Y4C0
TNSEKKYGPPQTCEQ	FAM76B	91	Q5HYJ3
YTNGHNEKSNCRKVP	KCNU1	846	A8MYU2
KYICQKPSIQKADGT	HUWE1	696	Q7Z6Z7
VCNGADFYGNQIKPK	HPN	321	P05981
QKKCQSKSPGLDNAY	LRRC66	406	Q68CR7
DIAGYDKSKNCPNDN	PPP4R3C	491	Q6ZMV5
NYCAGSQTKPLKQTC	PLA2G4E	726	Q3MJ16
NVKSYIKNNGSDCPS	CCSER2	46	Q9H7U1
PCEQKGLDNGYSISK	FLT3	391	P36888
NVTIYKKQSDCNVPD	IL1RL1	101	Q01638
QTSDSGIYKCTAKNP	IGSF10	2596	Q6WRI0
GRCQPNYKSGLVQKS	BCLAF3	656	A2AJT9
NPKYQCDLVSKNGND	DACT1	251	Q9NYF0
NCEKQSPDYKSNAVD	C6	551	P13671
VNNKVTSKSCEYNGT	CHRDL1	106	Q9BU40
GTYQCKVKKAPGVAN	CXADR	116	P78310
TYTPAQASCNEGKGK	F11	331	P03951
VGDYNTSEQKQACKK	BMP5	341	P22003
KTNAKLYCNRGTVNS	DNAJC7	291	Q99615
GYASQPCAKISEKGQ	FOXN2	366	P32314
NCAIPKGLKYNQATQ	ENAH	61	Q8N8S7
GQKDLLTPCYSRQNK	HEXB	301	P07686
TDPDGNPKCKSKINY	SEC14L2	246	O76054
NKEKCPPSAGQTYSQ	SACS	4416	Q9NZJ4
SNCNGKRKVQYESSE	CDH2	61	P19022
PSFSQNCLAYKNDKQ	ENPP2	661	Q13822
EPAYKSCKQENTASG	MYBL1	606	P10243
CEPSQNKQKGVGYFN	PRIMPOL	346	Q96LW4
TGCAQYDPTKNASKK	ITK	141	Q08881
SPYFKSNDVVCKNQD	FAN1	126	Q9Y2M0
IKNVQPSDQGHYKCS	PTGFRN	106	Q9P2B2
VKSCVIQSYKNNPNF	FER1L6	1026	Q2WGJ9
ADQSAGKNKNKFVPY	KIF13B	291	Q9NQT8
KIKQPNGFCDNYSAQ	MEIOC	581	A2RUB1
YPCAKTQKLVQDQSD	USH2A	3151	O75445
KEYTCKSLSDNGQPG	UTP20	1726	O75691
KGPVNSCQGKNYNLK	SMCHD1	891	A6NHR9
SGVYNVIPCSRKNAK	ALDH5A1	251	P51649
NYKDRCNVEKVPSNS	SMARCA2	1396	P51531
NCKQKPTEKPANYSV	TRHR	336	P34981
NKTYGCVPVANKRDT	SPAG7	186	O75391
SPQKFYCQLGRNNKD	TDRD15	976	B5MCY1
VDKATKNTLCNYDPS	NXPH1	201	P58417
YPAGVKQKCLRSQTS	LAMA1	3021	P25391
FYKQNKICTEQSNSP	PTPN14	301	Q15678
SFKGKDPQRDCQNYI	SEMA4B	121	Q9NPR2
AKESGYIAPQGACNK	SHROOM3	496	Q8TF72
DPKGNNFLYTNGKCV	WDR1	26	O75083
PSNADDCYQSKLKGK	SRR	211	Q9GZT4
TPSKKNYNDCIQGAL	PRORP	241	O15091
AEAQPSENKKTRYCN	SLCO1B1	11	Q9Y6L6
SSSGNKKPIVFYNCS	SLCO1B1	491	Q9Y6L6
DKICNQHNDPSKTTY	CCDC110	776	Q8TBZ0
SCRPKTHISKNYGNN	ZNF845	181	Q96IR2
PINKNHKCYNSTGVD	ROR1	306	Q01973
ALKACKTPQSQQSAY	RNF213	4356	Q63HN8
CAGNTDTKFQKLQYK	VPS50	296	Q96JG6
QEKYSRKPNVGCQQD	UBA6	336	A0AVT1
VAGNKLAKNVQYPEC	USP17L3	286	A6NCW0
PQETNSNTDNKPYKC	ZFHX4	1536	Q86UP3
PYKCNQCGKVFTQNS	ZNF160	676	Q9HCG1
VAGNKLAKNVQYPEC	USP17L4	286	A6NCW7
KSQQAGPSYVQNCVK	RNF111	96	Q6ZNA4
NQETKEEKSSYNCPL	RREB1	56	Q92766
KVCSDKNKPNGQYQI	POLK	321	Q9UBT6
KPNNSNKCAVAFYSG	ZNF211	211	Q13398
VAGNKLAKNVQYPEC	USP17L1	286	Q7RTZ2
KSPDKVNCVAKPNAY	ZNF518A	596	Q6AHZ1
TNQRIDNKCSTGYEK	NUP153	396	P49790
QEYGCVQQPKTQESK	ZMYM6	31	O95789
GQKPSQNGKCKQSFS	ZNF230	136	Q9UIE0
INNRNYSTKKIGCGN	ZNF510	191	Q9Y2H8
VTGNKLAKNVQYPKC	USP17L7	286	P0C7H9
YFACPQTKGGNKSTV	TUT4	706	Q5TAX3
SVEKPYKECGQTFSN	ZNF559	516	Q9BR84
VTGNKIDKNVQYPEC	USP17L15	286	C9J2P7
NNSLTPKYLGCKQDN	ZNF438	471	Q7Z4V0
SPSRKQNYSSKNENC	ZFC3H1	206	O60293
GCKQSSDLPRYQKVS	ZNF285	296	Q96NJ3
YGAKSCPQTSNKNQQ	ZPBP2	321	Q6X784
KLQKDYNGLNQCSST	ZNF195	196	O14628
DNCGQKDKPGVYTQV	TMPRSS11A	391	Q6ZMR5
YEIGSSKNKCSQVTP	ZNF804A	511	Q7Z570
QKTNKPTYNEEFCAN	PRKCH	61	P24723